Publication | Closed Access

Targeting SLP2-mediated lipid metabolism reprograming restricts proliferation and metastasis of hepatocellular carcinoma and promotes sensitivity to Lenvatinib

Slp2-mediated Lipid MetabolismTumor BiologyMedicineLiver PhysiologyRestricts ProliferationCancer BiologyLiver CancerTumor SuppressorPharmacologyCell BiologyHepatocellular CarcinomaCancer Research